ID CNTN5_HUMAN Reviewed; 1100 AA. AC O94779; A1L4P0; B7ZM07; E9PKE8; O94780; Q49AF3; DT 23-NOV-2004, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1999, sequence version 2. DT 27-MAR-2024, entry version 172. DE RecName: Full=Contactin-5; DE AltName: Full=Neural recognition molecule NB-2; DE Short=hNB-2; DE Flags: Precursor; GN Name=CNTN5; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND TISSUE SPECIFICITY. RC TISSUE=Cerebellum; RX PubMed=11013081; DOI=10.1006/geno.2000.6310; RA Kamei Y., Takeda Y., Teramoto K., Tsutsumi O., Taketani Y., Watanabe K.; RT "Human NB-2 of the contactin subgroup molecules: chromosomal localization RT of the gene (CNTN5) and distinct expression pattern from other subgroup RT members."; RL Genomics 69:113-119(2000). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16554811; DOI=10.1038/nature04632; RA Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., RA Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., RA Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G., RA Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C., RA Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A., RA Hattori M., Rogers J., Lander E.S., Sakaki Y.; RT "Human chromosome 11 DNA sequence and analysis including novel gene RT identification."; RL Nature 440:497-500(2006). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANTS RP VAL-530 AND THR-1079. RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP INTERACTION WITH PTPRG. RX PubMed=20133774; DOI=10.1073/pnas.0911235107; RA Bouyain S., Watkins D.J.; RT "The protein tyrosine phosphatases PTPRZ and PTPRG bind to distinct members RT of the contactin family of neural recognition molecules."; RL Proc. Natl. Acad. Sci. U.S.A. 107:2443-2448(2010). CC -!- FUNCTION: Contactins mediate cell surface interactions during nervous CC system development. Has some neurite outgrowth-promoting activity in CC the cerebral cortical neurons but not in hippocampal neurons. Probably CC involved in neuronal activity in the auditory system (By similarity). CC {ECO:0000250}. CC -!- SUBUNIT: Interacts with PTPRG. {ECO:0000269|PubMed:20133774}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor, GPI- CC anchor {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; Synonyms=Long; CC IsoId=O94779-1; Sequence=Displayed; CC Name=2; Synonyms=Short, HNB-2s; CC IsoId=O94779-2; Sequence=VSP_011967; CC Name=3; CC IsoId=O94779-4; Sequence=VSP_045995; CC -!- TISSUE SPECIFICITY: Expressed in brain and kidney and at very low level CC in placenta. Not expressed in other tissues. In brain, it is highly CC expressed in the occipital lobe, amygdala, cerebral cortex, frontal CC lobe, thalamus and temporal lobe. Expressed at moderate level in the CC cerebellum, substantia nigra, putamen, medulla and hippocampus. Weakly CC expressed in the spinal cord and caudate nucleus. Weakly or not CC expressed in the corpus callosum. {ECO:0000269|PubMed:11013081}. CC -!- SIMILARITY: Belongs to the immunoglobulin superfamily. Contactin CC family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAH39255.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB013802; BAA36579.2; -; mRNA. DR EMBL; AB013803; BAA36580.2; -; mRNA. DR EMBL; AP000760; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP000798; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP000923; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP001892; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP001988; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP002378; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP002428; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP002987; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP003126; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP003441; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP003558; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP004249; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC039255; AAH39255.1; ALT_SEQ; mRNA. DR EMBL; BC130619; AAI30620.1; -; mRNA. DR EMBL; BC144185; AAI44186.1; -; mRNA. DR CCDS; CCDS53696.1; -. [O94779-1] DR CCDS; CCDS53697.1; -. [O94779-2] DR CCDS; CCDS58168.1; -. [O94779-4] DR RefSeq; NP_001230199.1; NM_001243270.1. [O94779-1] DR RefSeq; NP_001230200.1; NM_001243271.1. [O94779-4] DR RefSeq; NP_055176.1; NM_014361.3. [O94779-1] DR RefSeq; NP_780775.1; NM_175566.2. [O94779-2] DR RefSeq; XP_011541173.1; XM_011542871.1. [O94779-2] DR RefSeq; XP_016873415.1; XM_017017926.1. [O94779-1] DR PDB; 4N68; X-ray; 1.80 A; A=871-971. DR PDB; 5E52; X-ray; 2.69 A; A=671-969. DR PDBsum; 4N68; -. DR PDBsum; 5E52; -. DR AlphaFoldDB; O94779; -. DR SMR; O94779; -. DR BioGRID; 119823; 1. DR IntAct; O94779; 3. DR STRING; 9606.ENSP00000435637; -. DR GlyCosmos; O94779; 9 sites, No reported glycans. DR GlyGen; O94779; 9 sites. DR iPTMnet; O94779; -. DR PhosphoSitePlus; O94779; -. DR BioMuta; CNTN5; -. DR MassIVE; O94779; -. DR PaxDb; 9606-ENSP00000435637; -. DR PeptideAtlas; O94779; -. DR ProteomicsDB; 21441; -. DR ProteomicsDB; 50439; -. [O94779-1] DR ProteomicsDB; 50440; -. [O94779-2] DR Antibodypedia; 31696; 185 antibodies from 23 providers. DR DNASU; 53942; -. DR Ensembl; ENST00000418526.6; ENSP00000393229.2; ENSG00000149972.12. [O94779-2] DR Ensembl; ENST00000524871.6; ENSP00000435637.1; ENSG00000149972.12. [O94779-1] DR Ensembl; ENST00000527185.5; ENSP00000433575.1; ENSG00000149972.12. [O94779-4] DR Ensembl; ENST00000528682.5; ENSP00000436185.1; ENSG00000149972.12. [O94779-1] DR GeneID; 53942; -. DR KEGG; hsa:53942; -. DR MANE-Select; ENST00000524871.6; ENSP00000435637.1; NM_014361.4; NP_055176.1. DR UCSC; uc001pfz.4; human. [O94779-1] DR AGR; HGNC:2175; -. DR CTD; 53942; -. DR DisGeNET; 53942; -. DR GeneCards; CNTN5; -. DR HGNC; HGNC:2175; CNTN5. DR HPA; ENSG00000149972; Tissue enhanced (brain, placenta, salivary gland, thyroid gland). DR MIM; 607219; gene. DR neXtProt; NX_O94779; -. DR OpenTargets; ENSG00000149972; -. DR PharmGKB; PA26689; -. DR VEuPathDB; HostDB:ENSG00000149972; -. DR eggNOG; KOG3513; Eukaryota. DR GeneTree; ENSGT00940000158183; -. DR HOGENOM; CLU_005756_0_0_1; -. DR InParanoid; O94779; -. DR OMA; CLTWTVL; -. DR OrthoDB; 3073820at2759; -. DR PhylomeDB; O94779; -. DR TreeFam; TF351103; -. DR PathwayCommons; O94779; -. DR Reactome; R-HSA-163125; Post-translational modification: synthesis of GPI-anchored proteins. DR SignaLink; O94779; -. DR BioGRID-ORCS; 53942; 12 hits in 1144 CRISPR screens. DR ChiTaRS; CNTN5; human. DR GenomeRNAi; 53942; -. DR Pharos; O94779; Tbio. DR PRO; PR:O94779; -. DR Proteomes; UP000005640; Chromosome 11. DR RNAct; O94779; Protein. DR Bgee; ENSG00000149972; Expressed in adrenal tissue and 94 other cell types or tissues. DR ExpressionAtlas; O94779; baseline and differential. DR Genevisible; O94779; HS. DR GO; GO:0030424; C:axon; IBA:GO_Central. DR GO; GO:0005576; C:extracellular region; TAS:Reactome. DR GO; GO:0098982; C:GABA-ergic synapse; IEA:Ensembl. DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central. DR GO; GO:0042734; C:presynaptic membrane; IEA:Ensembl. DR GO; GO:0098552; C:side of membrane; IEA:UniProtKB-KW. DR GO; GO:0098632; F:cell-cell adhesion mediator activity; IBA:GO_Central. DR GO; GO:0007411; P:axon guidance; IBA:GO_Central. DR GO; GO:0007420; P:brain development; IBA:GO_Central. DR GO; GO:0098609; P:cell-cell adhesion; IBA:GO_Central. DR GO; GO:0099054; P:presynapse assembly; IEA:Ensembl. DR GO; GO:0007605; P:sensory perception of sound; IEA:Ensembl. DR CDD; cd00063; FN3; 4. DR CDD; cd04969; Ig5_Contactin; 1. DR CDD; cd05848; IgI_1_Contactin-5; 1. DR Gene3D; 2.60.40.10; Immunoglobulins; 10. DR InterPro; IPR003961; FN3_dom. DR InterPro; IPR036116; FN3_sf. DR InterPro; IPR007110; Ig-like_dom. DR InterPro; IPR036179; Ig-like_dom_sf. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR013098; Ig_I-set. DR InterPro; IPR003599; Ig_sub. DR InterPro; IPR003598; Ig_sub2. DR PANTHER; PTHR44170:SF17; CONTACTIN-5; 1. DR PANTHER; PTHR44170; PROTEIN SIDEKICK; 1. DR Pfam; PF00041; fn3; 2. DR Pfam; PF07679; I-set; 4. DR Pfam; PF13927; Ig_3; 2. DR SMART; SM00060; FN3; 4. DR SMART; SM00409; IG; 6. DR SMART; SM00408; IGc2; 6. DR SUPFAM; SSF49265; Fibronectin type III; 2. DR SUPFAM; SSF48726; Immunoglobulin; 6. DR PROSITE; PS50853; FN3; 4. DR PROSITE; PS50835; IG_LIKE; 6. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Cell adhesion; Cell membrane; KW Disulfide bond; Glycoprotein; GPI-anchor; Immunoglobulin domain; KW Lipoprotein; Membrane; Reference proteome; Repeat; Signal. FT SIGNAL 1..18 FT /evidence="ECO:0000255" FT CHAIN 19..1072 FT /note="Contactin-5" FT /id="PRO_0000014717" FT PROPEP 1073..1100 FT /note="Removed in mature form" FT /evidence="ECO:0000255" FT /id="PRO_0000014718" FT DOMAIN 99..190 FT /note="Ig-like C2-type 1" FT DOMAIN 196..282 FT /note="Ig-like C2-type 2" FT DOMAIN 300..385 FT /note="Ig-like C2-type 3" FT DOMAIN 390..474 FT /note="Ig-like C2-type 4" FT DOMAIN 480..567 FT /note="Ig-like C2-type 5" FT DOMAIN 571..660 FT /note="Ig-like C2-type 6" FT DOMAIN 673..771 FT /note="Fibronectin type-III 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 776..873 FT /note="Fibronectin type-III 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 878..972 FT /note="Fibronectin type-III 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 977..1067 FT /note="Fibronectin type-III 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT REGION 959..982 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 961..982 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT LIPID 1072 FT /note="GPI-anchor amidated serine" FT /evidence="ECO:0000255" FT CARBOHYD 138 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 196 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 397 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 449 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 540 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 779 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 816 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 931 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1002 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 123..173 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" FT DISULFID 217..269 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" FT DISULFID 322..369 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" FT DISULFID 411..458 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" FT DISULFID 503..551 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" FT DISULFID 593..650 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" FT VAR_SEQ 19..92 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:11013081" FT /id="VSP_011967" FT VAR_SEQ 912..1100 FT /note="Missing (in isoform 3)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_045995" FT VARIANT 23 FT /note="S -> A (in dbSNP:rs10790978)" FT /id="VAR_019907" FT VARIANT 70 FT /note="L -> R (in dbSNP:rs7125822)" FT /id="VAR_019908" FT VARIANT 81 FT /note="N -> S (in dbSNP:rs10893933)" FT /id="VAR_019909" FT VARIANT 530 FT /note="I -> V (in dbSNP:rs11223168)" FT /evidence="ECO:0000269|PubMed:15489334" FT /id="VAR_019910" FT VARIANT 1065 FT /note="Y -> F (in dbSNP:rs1944169)" FT /id="VAR_019911" FT VARIANT 1079 FT /note="S -> T (in dbSNP:rs1216183)" FT /evidence="ECO:0000269|PubMed:15489334" FT /id="VAR_019912" FT VARIANT 1094 FT /note="M -> V (in dbSNP:rs35208161)" FT /id="VAR_033610" FT STRAND 677..682 FT /evidence="ECO:0007829|PDB:5E52" FT STRAND 684..691 FT /evidence="ECO:0007829|PDB:5E52" FT STRAND 703..709 FT /evidence="ECO:0007829|PDB:5E52" FT STRAND 721..727 FT /evidence="ECO:0007829|PDB:5E52" FT STRAND 732..737 FT /evidence="ECO:0007829|PDB:5E52" FT STRAND 743..751 FT /evidence="ECO:0007829|PDB:5E52" FT STRAND 778..782 FT /evidence="ECO:0007829|PDB:5E52" FT STRAND 789..795 FT /evidence="ECO:0007829|PDB:5E52" FT HELIX 799..801 FT /evidence="ECO:0007829|PDB:5E52" FT STRAND 804..806 FT /evidence="ECO:0007829|PDB:5E52" FT STRAND 808..815 FT /evidence="ECO:0007829|PDB:5E52" FT STRAND 822..826 FT /evidence="ECO:0007829|PDB:5E52" FT STRAND 833..837 FT /evidence="ECO:0007829|PDB:5E52" FT STRAND 839..841 FT /evidence="ECO:0007829|PDB:5E52" FT STRAND 846..855 FT /evidence="ECO:0007829|PDB:5E52" FT STRAND 858..862 FT /evidence="ECO:0007829|PDB:5E52" FT STRAND 866..871 FT /evidence="ECO:0007829|PDB:5E52" FT STRAND 880..886 FT /evidence="ECO:0007829|PDB:4N68" FT STRAND 888..890 FT /evidence="ECO:0007829|PDB:4N68" FT STRAND 892..897 FT /evidence="ECO:0007829|PDB:4N68" FT HELIX 901..903 FT /evidence="ECO:0007829|PDB:4N68" FT STRAND 907..915 FT /evidence="ECO:0007829|PDB:4N68" FT HELIX 920..922 FT /evidence="ECO:0007829|PDB:4N68" FT STRAND 924..927 FT /evidence="ECO:0007829|PDB:4N68" FT STRAND 929..931 FT /evidence="ECO:0007829|PDB:5E52" FT STRAND 934..937 FT /evidence="ECO:0007829|PDB:4N68" FT STRAND 945..954 FT /evidence="ECO:0007829|PDB:4N68" FT STRAND 965..968 FT /evidence="ECO:0007829|PDB:4N68" SQ SEQUENCE 1100 AA; 120686 MW; 5883575D84AD030E CRC64; MASSWKLMLF LSVTMCLSEY SKSLPGLSTS YAALLRIKKS SSSSLFGSKT RPRYSSPSLG TLSASSPSWL GAAQNYYSPI NLYHSSDAFK QDESVDYGPV FVQEPDDIIF PTDSDEKKVA LNCEVRGNPV PSYRWLRNGT EIDLESDYRY SLIDGTFIIS NPSEAKDSGH YQCLATNTVG SILSREATLQ FAYLGNFSGR TRSAVSVREG QGVVLMCSPP PHSPEIIYSW VFNEFPSFVA EDSRRFISQE TGNLYISKVQ TSDVGSYICL VKNTVTNARV LSPPTPLTLR NDGVMGEYEP KIEVHFPFTV TAAKGTTVKM ECFALGNPVP TITWMKVNGY IPSKARLRKS QAVLEIPNVQ LDDAGIYECR AENSRGKNSF RGQLQVYTYP HWVEKLNDTQ LDSGSPLRWE CKATGKPRPT YRWLKNGVPL SPQSRVEMVN GVLMIHNVNQ SDAGMYQCLA ENKYGAIYAS AELKILASAP TFALNQLKKT IIVTKDQEVV IECKPQGSPK PTISWKKGDR AVRENKRIAI LPDGSLRILN ASKSDEGKYV CRGENVFGSA EIIASLSVKE PTRIELTPKR TELTVGESIV LNCKAIHDAS LDVTFYWTLK GQPIDFEEEG GHFESIRAQA SSADLMIRNI LLMHAGRYGC RVQTTADSVS DEAELLVRGP PGPPGIVIVE EITESTATLS WSPAADNHSP ISSYNLQARS PFSLGWQTVK TVPEIITGDM ESAMAVDLNP WVEYEFRVVA TNPIGTGDPS TPSRMIRTNE AVPKTAPTNV SGRSGRRHEL VIAWEPVSEE FQNGEGFGYI VAFRPNGTRG WKEKMVTSSE ASKFIYRDES VPPLTPFEVK VGVYNNKGDG PFSQIVVICS AEGEPSAAPT DVKATSVSVS EILVAWKHIK ESLGRPQGFE VGYWKDMEQE DTAETVKTRG NESFVILTGL EGNTLYHFTV RAYNGAGYGP PSSEVSATTK KSPPSQAPSN LRWEQQGSQV SLGWEPVIPL ANESEVVGYK VFYRQEGHSN SQVIETQKLQ AVVPLPDAGV YIIEVRAYSE GGDGTASSQI RVPSYSGGKI TSAQSTLHSL STSSSSVTLL LALMIPSTSW //